Study title: A multicentre randomised, parallel group, double-blind phase III comparison between iodixanol (VISIPAQUE) 150 mg I/ml and 320 mg I/ml and iohexol (Omnipaque) 140 mg I/ml and 300 mg I/ml Report DXC060 (date Jun 1999)
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Diagnosis | |||||
Brands: Please see report, Please see report | |||||
MAH holders: Please see report, Please see report, Please see report | |||||
Assessment: | |||||
Active substance: IODIXANOL | |||||
ATC code: V08AB09 | |||||
Document link: DXC060 Redacted.pdf | |||||
Document date: 2013-10-07 | |||||
Study number: DXV060 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |